Patents-Review.com
🔗 Permalink
Assignee profile:

Merck Serono S.A.

City:

Vaud

Country:

Switzerland

Published Applications:

18

Last publication date:

2018-11-15

Patent Grants:

17

Last grant date:

2022-11-29

Top Inventors for applications by Merck Serono S.A.

These are the the leading inventors for applications assigned to Merck Serono S.A.:

Recent patent applications by Merck Serono S.A.

Merck Serono S.A. based in Vaud, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-11-15 ✅ Patent 11,513,120 granted on 2022-11-29
US20180328925A1
Physics

Membrane bound reporter molecules and their use in cell sorting

 #2 | 2014-02-20 ✅ Patent 8,841,459 granted on 2014-09-23
US20140051686A1
Chemistry; metallurgy

3-arylamino pyridine derivatives

 #3 | 2014-01-09
US20140011213A1
Physics

MEMBRANE BOUND REPORTER MOLECULES AND THEIR USE IN CELL SORTING

 #4 | 2014-01-02 ✅ Patent 9,574,003 granted on 2017-02-21
US20140005368A1
Chemistry; metallurgy

Low fucose cell lines and uses thereof

 #5 | 2013-10-10 ✅ Patent 8,658,640 granted on 2014-02-25
US20130267512A1
Chemistry; metallurgy

JNK inhibitors for the treatment of endometriosis

 #6 | 2012-11-22 ✅ Patent 8,524,911 granted on 2013-09-03
US20120295889A1
Chemistry; metallurgy

3-arylamino pyridine derivatives

 #7 | 2011-02-10 ✅ Patent 8,058,289 granted on 2011-11-15
US20110034458A1
Chemistry; metallurgy

Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors

 #8 | 2010-11-18 ✅ Patent 9,566,313 granted on 2017-02-14
US20100291028A1
Human necessities

Method of treating peripheral vascular diseases using IL-18 inhibitors

 #9 | 2010-07-29 ✅ Patent 8,278,286 granted on 2012-10-02
US20100189684A1
Human necessities

Use of gp130 activators in diabetic neuropathy

 #10 | 2009-12-24 ✅ Patent 8,236,963 granted on 2012-08-07
US20090318486A1
Chemistry; metallurgy

Tricyclic spiro derivatives as CRTH2 modulators

 #11 | 2009-09-03 ✅ Patent 7,879,876 granted on 2011-02-01
US20090221575A1
Chemistry; metallurgy

Sulfonamide derivatives and use thereof for the modulation of metalloproteinases

 #12 | 2009-01-29 ✅ Patent 8,802,861 granted on 2014-08-12
US20090029998A1
Chemistry; metallurgy

Thiazole derivatives and use thereof

 #13 | 2009-01-29 ✅ Patent 7,947,851 granted on 2011-05-24
US20090029903A1
Chemistry; metallurgy

1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors

 #14 | 2009-01-01 ✅ Patent 8,017,628 granted on 2011-09-13
US20090005426A1
Chemistry; metallurgy

Pharmaceutically active sulfonyl hydrazide derivatives

 #15 | 2008-10-16 ✅ Patent 8,008,341 granted on 2011-08-30
US20080255222A1
Chemistry; metallurgy

Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases

 #16 | 2008-06-19 ✅ Patent 7,932,389 granted on 2011-04-26
US20080146806A1
Chemistry; metallurgy

Octahydropyrrolo[2,3C]pyridine derivatives and pharmaceutical use thereof

 #17 | 2008-04-17 ✅ Patent 7,868,009 granted on 2011-01-11
US20080090838A1
Chemistry; metallurgy

N-hydroxyamide derivatives and use thereof

 #18 | 2007-08-30 ✅ Patent 8,431,534 granted on 2013-04-30
US20070203069A1
Human necessities

GRF-containing lyophilized pharmaceutical compositions

Also check out MERCK SERONO S.A.'s (Vaud, Switzerland) applicant profile with 5 patent applications submitted.

AssigneeID:

50742 ⎘